CHE logo

Chemed CorporationNYSE:CHE Stock Report

Market Cap US$6.3b
Share Price
US$435.33
My Fair Value
AN
AnalystConsensusTarget
US$567
23.3% undervalued intrinsic discount
1Y-25.0%
7D4.2%
Portfolio Value
​
View

Chemed Corporation

NYSE:CHE Stock Report

Market Cap: US$6.3b

Chemed (CHE) Stock Overview

Provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. More details

CHE fundamental analysis
Snowflake Score
Valuation4/6
Future Growth1/6
Past Performance2/6
Financial Health6/6
Dividends0/6

Rewards

Trading at 36.7% below our estimate of its fair value

Earnings are forecast to grow 7.71% per year

Analysts in good agreement that stock price will rise by 30.3%

Risk Analysis

Significant insider selling over the past 3 months


CHE Community Fair Values

Create Narrative

See what 7 others think this stock is worth. Follow their fair value or set your own to get alerts.

CHE logo
Chemed
AN
AnalystConsensusTarget
AnalystConsensusTarget
Consensus Narrative from 4 Analysts

New Florida CON Sites Will Advance Home-Based And Hospice Care

Key Takeaways Expansion into underserved Florida counties and demographic trends in aging support substantial, long-term growth for VITAS hospice services. Operational efficiency, technology investment, and robust Roto-Rooter cash flow position Chemed for margin improvements and strategic acquisition-led growth.
View narrative
US$567.25
FV
23.3% undervalued intrinsic discount
4.98%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
4 days ago author updated this narrative
View Stock Community

Chemed Corporation Competitors

Price History & Performance

Summary of share price highs, lows and changes for Chemed
Historical stock prices
Current Share PriceUS$435.33
52 Week HighUS$623.61
52 Week LowUS$408.42
Beta0.46
1 Month Change-5.34%
3 Month Change-23.51%
1 Year Change-24.95%
3 Year Change-11.29%
5 Year Change-14.05%
Change since IPO3,748.22%

Recent News & Updates

Recent updates

Chemed Corporation: Short-Term Headwinds But Long-Term Growth Potential

Jul 18

Chemed Corporation (NYSE:CHE) Shares Could Be 23% Below Their Intrinsic Value Estimate

Jul 07
Chemed Corporation (NYSE:CHE) Shares Could Be 23% Below Their Intrinsic Value Estimate

Chemed Corporation's (NYSE:CHE) Business Is Yet to Catch Up With Its Share Price

Jun 18
Chemed Corporation's (NYSE:CHE) Business Is Yet to Catch Up With Its Share Price

Here's What Analysts Are Forecasting For Chemed Corporation (NYSE:CHE) After Its First-Quarter Results

May 01
Here's What Analysts Are Forecasting For Chemed Corporation (NYSE:CHE) After Its First-Quarter Results

Why You Should Care About Chemed's (NYSE:CHE) Strong Returns On Capital

Apr 22
Why You Should Care About Chemed's (NYSE:CHE) Strong Returns On Capital

Here's Why We Think Chemed (NYSE:CHE) Is Well Worth Watching

Apr 07
Here's Why We Think Chemed (NYSE:CHE) Is Well Worth Watching

Chemed Corporation's (NYSE:CHE) Intrinsic Value Is Potentially 61% Above Its Share Price

Mar 21
Chemed Corporation's (NYSE:CHE) Intrinsic Value Is Potentially 61% Above Its Share Price

Chemed Corporation's (NYSE:CHE) Popularity With Investors Is Clear

Mar 06
Chemed Corporation's (NYSE:CHE) Popularity With Investors Is Clear

Investors Shouldn't Overlook The Favourable Returns On Capital At Chemed (NYSE:CHE)

Jan 03
Investors Shouldn't Overlook The Favourable Returns On Capital At Chemed (NYSE:CHE)

With EPS Growth And More, Chemed (NYSE:CHE) Makes An Interesting Case

Dec 18
With EPS Growth And More, Chemed (NYSE:CHE) Makes An Interesting Case

Is There An Opportunity With Chemed Corporation's (NYSE:CHE) 25% Undervaluation?

Dec 03
Is There An Opportunity With Chemed Corporation's (NYSE:CHE) 25% Undervaluation?

The Chemed Corporation (NYSE:CHE) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

Nov 01
The Chemed Corporation (NYSE:CHE) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

Chemed Corporation's (NYSE:CHE) Business Is Yet to Catch Up With Its Share Price

Oct 29
Chemed Corporation's (NYSE:CHE) Business Is Yet to Catch Up With Its Share Price

Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Aug 26
Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future
author-image

Strategic Acquisitions And Operational Efficiencies Set To Propel VITAS And Roto-Rooter Forward

Strategic acquisitions, such as Covenant Health, and aggressive hiring in VITAS are poised to enhance Chemed's revenue and net margins through improved operational efficiency.

Chemed Remains A Buy On Long-Term Economics

Aug 16

Chemed: Growth Does Not Justify The Current Stock Price

May 20

Chemed: Continues To Compound Shareholder Value At Double-Digit Returns

Nov 30

Shareholder Returns

CHEUS HealthcareUS Market
7D4.2%4.1%2.4%
1Y-25.0%-33.0%20.2%

Return vs Industry: CHE exceeded the US Healthcare industry which returned -33% over the past year.

Return vs Market: CHE underperformed the US Market which returned 20.2% over the past year.

Price Volatility

Is CHE's price volatile compared to industry and market?
CHE volatility
CHE Average Weekly Movement5.5%
Healthcare Industry Average Movement6.8%
Market Average Movement6.5%
10% most volatile stocks in US Market17.6%
10% least volatile stocks in US Market3.1%

Stable Share Price: CHE has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: CHE's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
197015,695Kevin McNamarawww.chemed.com

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Chemed Corporation Fundamentals Summary

How do Chemed's earnings and revenue compare to its market cap?
CHE fundamental statistics
Market capUS$6.32b
Earnings (TTM)US$290.35m
Revenue (TTM)US$2.51b
21.8x
P/E Ratio
2.5x
P/S Ratio

Is CHE overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CHE income statement (TTM)
RevenueUS$2.51b
Cost of RevenueUS$1.67b
Gross ProfitUS$845.22m
Other ExpensesUS$554.87m
EarningsUS$290.35m

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)20.00
Gross Margin33.65%
Net Profit Margin11.56%
Debt/Equity Ratio0%

How did CHE perform over the long term?

See historical performance and comparison

Dividends

0.6%
Current Dividend Yield
10%
Payout Ratio

Does CHE pay a reliable dividends?

See CHE dividend history and benchmarks
When do you need to buy CHE by to receive an upcoming dividend?
Chemed dividend dates
Ex Dividend DateAug 11 2025
Dividend Pay DateAug 29 2025
Days until Ex dividend0 days
Days until Dividend pay date18 days

Does CHE pay a reliable dividends?

See CHE dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/08/10 16:40
End of Day Share Price 2025/08/08 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Chemed Corporation is covered by 13 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ishan MajumdarBaptista Research
Adam FeinsteinBarclays
Joanna Sylvia GajukBofA Global Research